Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

7.840 +0.740 (+10.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals Inc Cl A

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Nvidia Is Betting Big on ARM Stock
Arm stock is up on Thursday after investors in the semiconductor company learned that graphics card company Nvidia holds a large stake in it. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Nvidia Bolsters AI Leadership with Investment in Arm Holdings, Eyes Future Growth in Semiconductor Industry
Nvidia's investment portfolio includes stakes in Arm Holdings, SoundHound AI, and Recursion Pharmaceuticals. Despite failed acquisition, Arm's market valuation has soared to $130 billion. Significant... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia Discloses Stakes In Arm, SoundHound AI, Nano-X And More
The AI chip leader revealed investments in its first-ever 13F SEC filing late Wednesday. 
Via Investor's Business Daily
Topics Artificial Intelligence Regulatory Compliance
Exposures Artificial Intelligence Legal Regulatory
A Glimpse Into The Expert Outlook On Recursion Pharmaceuticals Through 4 Analysts
Via Benzinga
What's Going On With Recursion Pharmaceuticals Stock?
Via Benzinga
Peering Into Recursion Pharmaceuticals's Recent Short Interest
Via Benzinga
2 Cathie Wood Stocks With Jaw-Dropping Growth Potential
These two platform biotechs could revolutionize the field of biologically based products. 
Via The Motley Fool
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood Just Bought These 3 Biotech Stocks. Should You?
They aren't all long shots, but they're all innovative. 
Via The Motley Fool
2 Under-the-Radar Stocks With Incredible Upside Potential
It's also important to consider their downsides. 
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week
The widely followed growth stock investor is adding to some of her holdings this week. 
Via The Motley Fool
Altitude Lab Startups Raise Over $120M in Capital
Launches Fellowship Grant Opportunity for Early Career Entrepreneurs 
From Recursion Pharmaceuticals
Via GlobeNewswire
Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
These companies are still in the early innings of their growth potential. 
Via The Motley Fool
Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights
Nvidia provides artificial intelligence solutions for various markets, including the healthcare and automotive industries. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
These companies could stand out thanks to game-changing technology. 
Via The Motley Fool
Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now. 
Via InvestorPlace
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
Recursion and NVIDIA will host an invite-only event on Wednesday, January 10, where Recursion will provide live demonstrations of LOWE, its new LLM-based software that can perform complex drug... 
From Recursion Pharmaceuticals
Via GlobeNewswire
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following... 
Via Benzinga
Topics Stocks
Exposures US Equities
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer 
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought in 2024
The widely followed aggressive growth investor is adding to some of her holdings as she kicks off the new year. 
Via The Motley Fool
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
From Recursion Pharmaceuticals
Via GlobeNewswire
Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock
Via Benzinga
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today. 
Via InvestorPlace
AI-Focused Drug Discovery Stocks Index Up 26% In December
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. 
Via Talk Markets
Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher
On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before. 
Via Investor's Business Daily
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets. 
From Recursion Pharmaceuticals
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.